SJ Investment Partners

SJ Investment Partners is a venture capital firm based in Seoul, South Korea, specializing in investments within the information technology and biotechnology sectors. The firm manages the SJ Social Impact Bio Venture Fund, which focuses on environmental, social, and governance (ESG) criteria, as well as impact investments aimed at improving health outcomes. Through its strategic investments, SJ Investment Partners aims to support innovative companies that contribute positively to society while generating financial returns.

Ok Jin-woo

director

12 past transactions

Deaver

Series A in 2022
Deaver is an app for delivery management services.

Deaver

Series A in 2022
Deaver is an app for delivery management services.

S-Alpha Therapeutics

Series A in 2021
S-Alpha Therapeutics Inc., a digital therapeutics company, researches and develops health applications and platform technologies that enable digital devices to treat different diseases. Its products include SAT-001, an ophthalmology related application for eye disease treatment; SAT-002, neurology application for treatment of nervous system disease; SAT-003, oncology application for recovery and treatment of cancer patients; and SAT-008, a public crisis application for overcoming social problems. Additionally, it also develops therapeutic devices. The company was founded in 2019 and is based in Seoul, South Korea.

House of Rebels

Series A in 2019
Operator of an intellectual property-commerce group intended to expand media and brands. The company media platform promotes creative works, building events, products, and brands in collaboration with a number of artists and creators, mostly from the subculture scene, enabling users to explore different cultures and brands.

AIONCO KOREA Co

Venture Round in 2019
AIONCO KOREA provides competitive item sourcing and logistics solution service to cross border eCommerce clients. AIONCO specializes in the delivery of exceptional Multi-Channel Fulfillment solutions. From pallets to beautifully gift wrapped packages, they provide a streamlined, single-source solution that optimizes the supply chain across all channels for brands in both the direct-to-consumer and wholesale arenas. The company was established in 2015 and is based in Seoul, Korea.

BOMAPP

Series A in 2019
Bomapp Inc., founded in 2015 and based in Seoul, South Korea, is a leading insurtech company that develops and operates the Bomapp application, an integrated mobile insurance manager. The app aims to simplify the insurance experience for users by offering features such as personalized coverage reports through its “Bomapp Coverage Fitting” service, as well as tools for current policy lookup, easy claims, and complimentary public insurance information. With over 2.2 million downloads and 1.7 million registered users as of July 2020, Bomapp seeks to engage a wider audience in the insurance market. In addition to its business-to-consumer offerings, the company is expanding into business-to-business and business-to-business-to-consumer sectors, addressing the insurance needs of small and medium-sized enterprises and platform service providers. Bomapp's mission is to enhance the digital insurance landscape by providing a seamless, user-friendly experience that allows consumers to compare and apply for insurance coverage easily and at more competitive rates.

Inventage lab

Seed Round in 2018
inventory Lab is promoting the development of new and improved drugs for the treatment of refractory and chronic diseases by establishing a new drug delivery system. In addition, inventory will strategically develop various consumer-oriented pipelines to create new values ​​of human happiness and technological innovation.

Tripbtoz

Seed Round in 2018
Tripbtoz, Inc. owns and operates an online hotel booking platform. It offers social travel platform that enables user to shoot and share travel videos. Tripbtoz, Inc. was founded in 2015 and is based in Seoul, South Korea.

Todoc

Series A in 2018
Todoc is a technology leader in the field of neural prosthesis and neuromodulation in Korea, specializing in the development of advanced cochlear implant systems. The company aims to address the high costs associated with cochlear implants, which have traditionally limited access to hearing restoration for individuals in developing countries. Todoc's innovative approach involves automated micro-machining processes to manufacture neural electrodes, significantly reducing production costs to one-tenth of conventional methods. This advancement not only makes cochlear implants more affordable but also enhances their performance by offering a wider range of sound capabilities. The company's 32-channel cochlear implant system stands out with the highest number of channels available, utilizing wireless transmission technology for effective data transfer. Todoc's mission is to expand the global cochlear implant market and establish itself as a leader in the Brain-Machine Interface sector through its superior neural interface technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.